These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7490329)

  • 1. Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon alpha-2b.
    Siboni A; Mourits-Andersen T; Moesner J
    J Clin Pathol; 1995 Sep; 48(9):878-80. PubMed ID: 7490329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of resistance to lymphoblastoid interferon alpha in chronic myeloid leukaemia.
    Barton LM; Green AR
    Br J Haematol; 1998 Dec; 103(4):1208-9. PubMed ID: 9886345
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
    Shepherd PC; Richards S; Allan NC
    Br J Haematol; 1994 Jan; 86(1):92-6. PubMed ID: 8011552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation.
    Arcese W; Mauro FR; Screnci M; Alimena G; Lo Coco F; Iori AP; de Cuia MR; Fazi P; Montefusco E; Mandelli F
    Eur J Cancer; 1991; 27 Suppl 4():S28-30. PubMed ID: 1799471
    [No Abstract]   [Full Text] [Related]  

  • 6. Crescentic glomerulonephritis during treatment with interferon-alpha 2b.
    Durand JM; Retornaz F; Cretel E; Kaplanski G; Soubeyrand J
    Am J Hematol; 1995 Feb; 48(2):140-1. PubMed ID: 7847342
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
    Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
    Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia.
    Wandl UB; Kloke O; Nagel-Hiemke M; Moritz T; Becher R; Opalka B; Holtkamp W; Bartels H; Seeber S; Niederle N
    Br J Haematol; 1992 Aug; 81(4):516-9. PubMed ID: 1390238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: preliminary results of an open French multicentre randomized study.
    Broustet A; Reiffers J; Marit G; Fiere D; Jaubert J; Reynaud J; Pris J; Bernard P; Charrin C; Wen ZQ
    Eur J Cancer; 1991; 27 Suppl 4():S18-21. PubMed ID: 1799467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.
    Jadoul M; Piessevaux H; Ferrant A; Cosyns JP; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1995; 10(1):111-3. PubMed ID: 7724004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with interferon alfa-2a in the chronic phase of Philadelphia-positive chronic myeloid leukemia].
    Steegmann JL; Lavilla E; Somolinos N; Pérez-Sánchez M; Lamana M; Olmeda F; Cámara R; Arranz R; Ferro MT; Fernández-Rañada JM
    Sangre (Barc); 1992 Oct; 37(5):375-81. PubMed ID: 1293778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow necrosis at transformation of chronic granulocytic leukaemia treated with interferon.
    Kendra JR; Pickens S; Singh AK
    J Clin Pathol; 1992 Sep; 45(9):830-1. PubMed ID: 1401221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interferon-alpha in chronic myeloid leukemia.
    Kumar L; Basade M; Gulati SC
    J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant.
    Alabdulaaly A; Rifkind J; Solow H; Messner HA; Lipton JH
    Leuk Lymphoma; 2004 Jan; 45(1):175-7. PubMed ID: 15061216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa-2a for chronic myeloid leukemia.
    Atkins CD
    N Engl J Med; 1994 Aug; 331(6):401-2. PubMed ID: 8028627
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP; Finkelstein SD; Rabinovitz M
    Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged hematological remission by mitoxantrone and interferon--alpha-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia.
    Duru F; Tuncer M; Hiçsönmez G
    Eur J Haematol; 1993 Sep; 51(3):173-4. PubMed ID: 8405332
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon alfa-2a for chronic myeloid leukemia.
    Mehta J
    N Engl J Med; 1994 Aug; 331(6):401; author reply 402. PubMed ID: 8068137
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha.
    Peñarrubia MJ; Steegmann JL; Lavilla E; Casado F; Requena MJ; Picó M; Arranz R; Fernández-Rañada JM
    Am J Hematol; 1995 Jul; 49(3):240-1. PubMed ID: 7604817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.